Effect of Therapeutic Inhibition of TNF on Circulating Endothelial Progenitor Cells in Patients with Rheumatoid Arthritis
Endothelial dysfunction has been detected in RA patients and seems to be reversed by control of inflammation. Low circulating endothelial progenitor cells (EPCs) have been described in many conditions associated with increased cardiovascular risk, including RA. The aim of this study was to investiga...
Saved in:
Main Authors: | F. R. Spinelli, A. Metere, C. Barbati, M. Pierdominici, C. Iannuccelli, B. Lucchino, F. Ciciarello, L. Agati, G. Valesini, M. Di Franco |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2013/537539 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Asymmetric Dimethyl Arginine as a Biomarker of Atherosclerosis in Rheumatoid Arthritis
by: Manuela Di Franco, et al.
Published: (2018-01-01) -
Cost Effectiveness of TNF-α Inhibitors in Rheumatoid Arthritis
by: Cynthia Said, et al.
Published: (2013-01-01) -
Chronic endothelial inflammation in PWH leads to reduced circulating megakaryocyte progenitor cells
by: Tong Li, et al.
Published: (2025-02-01) -
Circulating Adipokines and Response to Treatment in Patients With Early Rheumatoid Arthritis
by: Georgios K. Vasileiadis, et al.
Published: (2025-01-01) -
The Effect of TNF-α on CHD and the Relationship between TNF-α Antagonist and CHD in Rheumatoid Arthritis: A Systematic Review
by: Yezhou Qian, et al.
Published: (2022-01-01)